A STUDY COMPARING BLOOD FLOW AND CLINICAL AND SAFETY EFFECTS OF THE ADDITION OF NATRECOR (NESIRITIDE), PLACEBO OR INTRAVENOUS NITROGLYCERIN TO STANDARD CARE FOR THE TREATMENT OF WORSENING CONGESTIVE HEART FAILURE.: